Delighted to share my PhD work is now published in Nat Commun! 💯
We established a large HCC dataset including 529 tumors from 461 patients treated in Western countries, integrating WGS/WES, RNA-seq, DNA methylation and proteomics data.
https://t.co/PikMHtqIQC
🖥️ Découvrez les coulisses de la dernière extension de Jean Zay, qui multiplie par 4 sa puissance de calcul !
Plus d'informations sur Jean Zay et cette extension ▶ https://t.co/ee9Xx8F7yI
Découvrez l'intégralité du reportage photo ▶ https://t.co/ODxDORbgNg
The human proteomic revolution proceeds with high-throughput assessment, AI analytics, correlation with health and disease, drug interactions, biomarkers
https://t.co/VsYD6vGxXp
#GUTImage from the paper by @campani_claudia et al
"Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments" via
https://t.co/Ew0p8jMp3N
@Zucmanrossi@NaultJc#HCC
#GUTImage from the paper by @campani_claudia et al
"Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments" via
https://t.co/Ew0p8jMp3N
@Zucmanrossi@NaultJc#HCC
1) Our manuscript entitled « Circulating tumour DNA in patients with hepatocellular carcinoma across tumour stages and treatments” was recently released in Gut
https://t.co/ltZjV3uUQC
@campani_claudia @CRCordeliers @SRebouissou@GUTJournal_BMJ@TZ_Hirsch@SImbeaud
Incredible resource: analysis of Whole Genome Sequencing data on 10,478 cancer patients spanning 35 types identifies 330 candidate driver genes, including 74 new drivers.
TP53 is a driver in 29‼️tumor types, followed by PIK3CA(18), ARID1A(16) & PTEN (14)
https://t.co/Q6Y00l4F4f
1) Our review on pediatric hepatocellular adenomas (HCA) was just released in J Hep Reports
https://t.co/CC6HlNYEjn
We performed an analysis of all the data about HCA developed in children in the literature
@RERC_SNCF c’est juste un peu de neige … prévu depuis 3 jours mais tout est bloqué sur la ligne.. Les destinations changent et les trains annulés au dernier moment.
De plus les quais ne sont pas sablés (gare de Vitry sur Seine). C’est très glissant. Vous nous mettez en danger.
Venez nous rejoindre @CRCordeliers (Paris, France) et devenez le futur responsable opérationnel de la nouvelle plateforme de Bio-informatique.
@Zucmanrossi@DeReynies
Ingénieur-e biologiste en analyse de données https://t.co/ER4XnTszso
I am truly honoured to have had the opportunity and fortune to share this journey with fabulous colleagues and two more than exceptional mentors @NaultJc@fabiomarra_dr
Don’t hesitate to register for this free event later today!! We’ll discuss the challenges of Molecular Tumor Boards for Hepatocellular Carcinoma #LiverTwitter
The #gnomAD team is proud to announce the release of gnomAD v4! The v4 dataset includes 730,947 exomes & 76,215 genomes, which is ~5x larger than the v2 & v3 releases combined, & includes nearly 120K indivs of non-European genetic ancestry https://t.co/YKXIFlZwSi #ASHG23 (1/11)
Our work “Impact of radiological response and pattern of progression in patients with hepatocellular carcinoma treated by atezolizumab-bevacizumab” was published in @hepatology@allaire_manon@campani_claudia
https://t.co/HGzkClH18r